Regent Pacific Group Limited (RPGLF)
OTCMKTS · Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
At close: Aug 25, 2025
Regent Pacific Group Market Cap
Regent Pacific Group has a market cap or net worth of $27.34 million as of September 9, 2025. Its market cap has increased by 107.32% in one year.
Market Cap
27.34M
Enterprise Value
28.97M
Revenue
833.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since March 10, 2016, Regent Pacific Group's market cap has decreased from 1.68B to 27.34M, a decrease of -98.37%. That is a compound annual growth rate of -35.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 27.34M | 154.67% |
| Dec 31, 2024 | 10.73M | -40.78% |
| Dec 29, 2023 | 18.13M | -25.46% |
| Dec 30, 2022 | 24.32M | -48.68% |
| Dec 31, 2021 | 47.39M | -17.68% |
| Dec 31, 2020 | 57.56M | 103.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 780.18M |
| Elite Pharmaceuticals | 742.62M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 345.48M |